Search research articles
Contact Us
Filters
Showing results (1-10 of 46) with videos related to
Page
of 5
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
July 7, 2000
Interactions between tumour cells and stromal cells and proteolytic modification of the extracellular matrix by metalloproteinases in cancer
Y A DeClerck
Cancer Cell
|
February 13, 2024
Envision the future of precision medicine in pediatric cancer
Y A DeClerck
Archives of Biochemistry and Biophysics
|
August 15, 1988
Purification and characterization of a collagenase inhibitor produced by bovine vascular smooth muscle cells
Y A DeClerck
Journal of the National Cancer Institute
|
September 1, 1985
Collagen biosynthesis in human neuroblastoma cell lines: evidence for expression of glial cell properties
Y A DeClerck, C Lee
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1994
Protease inhibitors: role and potential therapeutic use in human cancer
Y A DeClerck, S Imren
Molecular Biology of the Cell
|
August 1, 1997
Tissue inhibitor of metalloproteinases-2 is expressed in the interstitial matrix in adult mouse organs and during embryonic development
L Blavier, Y A DeClerck
Cancer Research
|
September 1, 1980
Destruction of extracellular matrices containing glycoproteins, elastin, and collagen by metastatic human tumor cells
P A Jones, Y A DeClerck
Cancer Research
|
September 1, 1980
Effect of ascorbic acid on the resistance of the extracellular matrix to hydrolysis by tumor cells
Y A DeClerck, P A Jones
Enzyme & Protein
|
January 1, 1996
Cooperation between matrix metalloproteinases and the plasminogen activator-plasmin system in tumor progression
Y A DeClerck, W E Laug
Cancer Research
|
July 1, 1986
Inhibition of tumor cell collagenolytic activity by bovine endothelial cells
Y A DeClerck, W E Laug
Page
of 5
Search research articles
Search
Showing results (1-10 of 46) with videos related to
Sort By:
Page
of 5
European Journal of Cancer (Oxford, England : 1990)
|
July 7, 2000
Interactions between tumour cells and stromal cells and proteolytic modification of the extracellular matrix by metalloproteinases in cancer
Y A DeClerck
Cancer Cell
|
February 13, 2024
Envision the future of precision medicine in pediatric cancer
Y A DeClerck
Archives of Biochemistry and Biophysics
|
August 15, 1988
Purification and characterization of a collagenase inhibitor produced by bovine vascular smooth muscle cells
Y A DeClerck
Journal of the National Cancer Institute
|
September 1, 1985
Collagen biosynthesis in human neuroblastoma cell lines: evidence for expression of glial cell properties
Y A DeClerck, C Lee
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1994
Protease inhibitors: role and potential therapeutic use in human cancer
Y A DeClerck, S Imren
Molecular Biology of the Cell
|
August 1, 1997
Tissue inhibitor of metalloproteinases-2 is expressed in the interstitial matrix in adult mouse organs and during embryonic development
L Blavier, Y A DeClerck
Cancer Research
|
September 1, 1980
Destruction of extracellular matrices containing glycoproteins, elastin, and collagen by metastatic human tumor cells
P A Jones, Y A DeClerck
Cancer Research
|
September 1, 1980
Effect of ascorbic acid on the resistance of the extracellular matrix to hydrolysis by tumor cells
Y A DeClerck, P A Jones
Enzyme & Protein
|
January 1, 1996
Cooperation between matrix metalloproteinases and the plasminogen activator-plasmin system in tumor progression
Y A DeClerck, W E Laug
Cancer Research
|
July 1, 1986
Inhibition of tumor cell collagenolytic activity by bovine endothelial cells
Y A DeClerck, W E Laug
Page
of 5